Please assess the completion status of the following clinical trial:

Trial Title: Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age\>18yr~* ReactivePulmonary Hypertension in Left Heart Failure: mPAP≥25 mmHg, PCWP\>15 mmHg and pulmonary vascular resistance (PVR) \[The PVR =(mPAP-PCWP)/ carbon monoxide\]\>3.0 woods unit~* Voluntary acceptance of all follow-up assessment of program requirements.~Exclusion Criteria:~* WHO group I, III, IV, V pulmonary artery hypertension~* Severe Renal dysfunction (Ccr\<30 ml/min)~* Blood platelet count\<100,000/L~* Expected life span\<12-month~* In pregnancy~* Systematical inflammation~* Malignant cancer(s)~* Tricuspid valve stenosis, Supra-pulmonary valve stenosis~* Allergic to studied drugs or metal materials

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pulmonary Arterial Denervation (PADN) (Type: EXPERIMENTAL): Contrast pulmonary artery （PA) angiography was performed to localize the pulmonary artery bifurcation level and calculate the PA diameter.Once the anatomy was deemed acceptable, the radiofrequency ablation catheter was introduced into ostium of the left PA, ostium of the right PA , and the distal bifurcation area of the main PA.This was then maneuvered within the PA to allow energy delivery in a circumferential manner to ensure that the electrodes were tightly in contact with the endovascular surface. About four to eight ablations at 10 W for 60 seconds each were performed in ostium of the left PA, ostium of the right PA , and the distal bifurcation area of the main PA.
- Standard treatment (Type: ACTIVE_COMPARATOR): Patients in the standard treatment group will take their baseline anti-heart failure medications at the original doses, without any changes except when medically required.The anti-heart failure drugs treatment is consistent in both arms.

Based on this trial design, predict the completion outcome and termination type (if applicable).